{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fhiv-pep-QI9ss0k5","width":444,"version":"1.0","type":"rich","title":"Key Decisions in HIV Care: Postexposure Prophylaxis","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/f51a2661-e00d-4328-9ec8-f5d357d546c9/key-decisions-mm-podcasticon-mm22.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/91683e2f-fd23-49b3-bd10-f1a5e109e805\" height=\"200\" width=\"100%\" title=\"Key Decisions in HIV Care: Postexposure Prophylaxis\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen as Dr Michelle D. Collins-Ogle shares data and recommendations for HIV PEP, including currently recommended regimens, single-tablet regimens, and pre-exposure prophylaxis following PEP."}